Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Epitope of somatic mutations in the hepatocyte growth factor receptor naturally processed and presented by HLA-A2 on human hepatocellular carcinoma].

Zhonghua yi xue za zhi - 10 Jan 2001

Guo A, Sui Y, Ye J

Abstract excerpt

OBJECTIVE: To isolate and identify peptides bound to HLA I on human hepatocellular carcinoma. METHODS: MHC-associated peptides were extracted by mild acid wash of viable hepatocellular carcinomas cells, collected by gel filtration, and fractioned by reversed phase high pressured liquid chromatography (RP-HPLC). Peptides of individual fractions were reconstitution of T cell epitopes and were identified by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Chromatography, High Pressure Liquid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytotoxicity Tests, Immunologic

Share to Epitopes, T-Lymphocyte

Share to HLA-A2 Antigen

Share to K562 Cells

Share to Liver Neoplasms

Share to Proto-Oncogene Proteins c-met

Source

Identifiers

PMID: 11798848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

[Epitope of somatic mutations in the hepatocyte growth factor receptor naturally processed and presented by HLA-A2 on human hepatocellular carcinoma].PMID 11798848Read ↗

Analysis of the HLA class I associated peptide repertoire in a hepatocellular carcinoma cell line reveals tumor-specific peptides as putative targets for immunotherapy.Semantic proximity Read ↗

Detecting tumor-associated peptides from the plasma-derived soluble immunopeptidome in human hepatocellular carcinoma patients: a pilot studySemantic proximity Read ↗

Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.Semantic proximity Read ↗

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.Semantic proximity Read ↗

Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and BenefitSemantic proximity Read ↗

Discovery and validation of non-canonical antigens for Hepatocellular Carcinoma immunotherapySemantic proximity Read ↗

[Prediction and identification of autoepitopes of PDC-E2 specific CD8+ CTL in primary biliary cirrhosis patients].Semantic proximity Read ↗

Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells.Semantic proximity Read ↗

Hepatocellular carcinoma: From bedside to proteomicsSemantic proximity Read ↗

[Multiomics study of HepG2 cell line proteome].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.